Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases.

antiplatelet clopidogrel human drug metabolites prasugrel thienopyridine unspecific peroxygenase

Journal

Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827

Informations de publication

Date de publication:
13 Sep 2021
Historique:
received: 27 08 2021
revised: 10 09 2021
accepted: 10 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the active thiol metabolites. These metabolites are the active compounds that inhibit the platelet P2Y

Identifiants

pubmed: 34575790
pii: jof7090752
doi: 10.3390/jof7090752
pmc: PMC8470877
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 031B0831
Organisme : Brandenburger Staatsministerium für Wissenschaft, Forschung und Kultur
ID : 22-F241-03-FhG/005/001
Organisme : Brandenburger Staatsministerium für Wissenschaft, Forschung und Kultur
ID : INST 263/88-1 LAGG

Références

Appl Environ Microbiol. 2004 Aug;70(8):4575-81
pubmed: 15294788
Chem Res Toxicol. 2010 Jul 19;23(7):1268-74
pubmed: 20557086
J Org Chem. 2002 Oct 18;67(21):7261-6
pubmed: 12375952
N Engl J Med. 2009 Jan 22;360(4):354-62
pubmed: 19106084
AMB Express. 2011 Oct 11;1(1):31
pubmed: 21988939
Drug Metab Dispos. 2010 Jan;38(1):92-9
pubmed: 19812348
Thromb Haemost. 2011 Apr;105(4):696-705
pubmed: 21301779
Drug Metab Dispos. 2002 Nov;30(11):1288-95
pubmed: 12386137
Chem Res Toxicol. 2015 Jun 15;28(6):1338-45
pubmed: 25970225
J Clin Pharmacol. 2010 Feb;50(2):126-42
pubmed: 19948947
Chem Res Toxicol. 2009 Feb;22(2):369-73
pubmed: 19170597
Chem Res Toxicol. 2012 Apr 16;25(4):895-903
pubmed: 22329513
Biotechnol Bioeng. 2021 Aug;118(8):3002-3014
pubmed: 33964174
J Inorg Biochem. 2018 Jun;183:84-93
pubmed: 29604496
Chembiochem. 2016 Feb 15;17(4):341-9
pubmed: 26677801
Biotechnol Adv. 2021 Nov 1;51:107615
pubmed: 32827669
Front Microbiol. 2017 Aug 09;8:1463
pubmed: 28848501
AMB Express. 2020 Jul 18;10(1):128
pubmed: 32683510
Drugs. 2000 Aug;60(2):347-77
pubmed: 10983738
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Dec 12;911:105-12
pubmed: 23217313
Bioorg Med Chem Lett. 2016 Jun 15;26(12):2739-2754
pubmed: 27133596
Drug Metab Dispos. 2008 Jul;36(7):1227-32
pubmed: 18372401
J Org Chem. 2015 Jul 17;80(14):7019-32
pubmed: 26151079
Org Process Res Dev. 2021 Jun 18;25(6):1414-1418
pubmed: 34168423
Appl Microbiol Biotechnol. 2009 Apr;82(6):1057-66
pubmed: 19039585
J Pharmacol Exp Ther. 2013 Mar;344(3):665-72
pubmed: 23275066
N Engl J Med. 2007 Nov 15;357(20):2001-15
pubmed: 17982182
Drug Metab Dispos. 2010 Jun;38(6):898-904
pubmed: 20228231
Appl Environ Microbiol. 2007 Sep;73(17):5477-85
pubmed: 17601809
Chembiochem. 2017 Mar 16;18(6):563-569
pubmed: 28103392
Thromb Haemost. 2005 Sep;94(3):593-8
pubmed: 16268477
Drug Metab Dispos. 2007 Jul;35(7):1096-104
pubmed: 17403916
J Am Chem Soc. 2003 Jun 18;125(24):7413-24
pubmed: 12797816
Eur Heart J. 2012 Nov;33(22):2856-2464a
pubmed: 22374717
AMB Express. 2013 Jan 17;3(1):5
pubmed: 23327645
Bioorg Med Chem. 2015 Aug 1;23(15):4324-4332
pubmed: 26142319
Adv Exp Med Biol. 2015;851:341-68
pubmed: 26002742
Drug Metab Dispos. 2007 Jun;35(6):917-21
pubmed: 17353347
Enzyme Microb Technol. 2015 Jun;73-74:29-33
pubmed: 26002501
Biotechnol Adv. 2021 Nov 1;51:107703
pubmed: 33545329
Chem Res Toxicol. 2012 Feb 20;25(2):348-56
pubmed: 22103858
Nat Med. 2011 Sep 07;17(9):1040-1; author reply 1042-4
pubmed: 21900914
JAMA. 2009 Aug 26;302(8):849-57
pubmed: 19706858
Appl Environ Microbiol. 2020 Mar 18;86(7):
pubmed: 31980430
Chem Rev. 2004 Sep;104(9):3947-80
pubmed: 15352783
Biotechnol Bioeng. 2013 Sep;110(9):2323-32
pubmed: 23519689
Chem Res Toxicol. 2013 May 20;26(5):794-802
pubmed: 23527615

Auteurs

Jan Kiebist (J)

Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany.
Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses, Am Mühlenberg 13, 14476 Potsdam-Golm, Germany.

Kai-Uwe Schmidtke (KU)

Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany.

Marina Schramm (M)

Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany.

Rosalie König (R)

Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany.

Stephan Quint (S)

Chiracon GmbH, Im Biotechnologiepark 9, 14943 Luckenwalde, Germany.

Johannes Kohlmann (J)

Chiracon GmbH, Im Biotechnologiepark 9, 14943 Luckenwalde, Germany.

Ralf Zuhse (R)

Chiracon GmbH, Im Biotechnologiepark 9, 14943 Luckenwalde, Germany.

René Ullrich (R)

Department of Bio- and Environmental Sciences, TU Dresden-International Institute Zittau, Markt 23, 02763 Zittau, Germany.

Martin Hofrichter (M)

Department of Bio- and Environmental Sciences, TU Dresden-International Institute Zittau, Markt 23, 02763 Zittau, Germany.

Katrin Scheibner (K)

Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Universitätsplatz 1, 01968 Senftenberg, Germany.

Classifications MeSH